Currently President and CEO of Tundra Targeted Therapeutics. Previously, Jed led TASC Ventures, an early-stage fund investing in fintech, insuretech, and HRtech startups transforming the employee benefits industry. Prior to launching the fund, Jed helped bring biomedical products to market at DSM and served as VP of Business Development from pre-Series A through exit at Nerites Corporation. He has an MBA from Kellogg and a BA from Williams College.